2DR Stock Overview
A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 2DR from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Inspire Medical Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$176.05 |
| 52 Week High | US$233.30 |
| 52 Week Low | US$114.65 |
| Beta | 1.31 |
| 1 Month Change | 2.15% |
| 3 Month Change | -5.50% |
| 1 Year Change | 0.60% |
| 3 Year Change | -15.12% |
| 5 Year Change | 172.95% |
| Change since IPO | 516.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2DR | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -0.03% | -2.9% | -2.6% |
| 1Y | 0.6% | -8.5% | 6.9% |
Return vs Industry: 2DR exceeded the German Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: 2DR underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| 2DR volatility | |
|---|---|
| 2DR Average Weekly Movement | 5.6% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2DR has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2DR's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 1,011 | Tim Herbert | www.inspiresleep.com |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
Inspire Medical Systems, Inc. Fundamentals Summary
| 2DR fundamental statistics | |
|---|---|
| Market cap | €5.33b |
| Earnings (TTM) | €31.67m |
| Revenue (TTM) | €724.16m |
170.3x
P/E Ratio7.4x
P/S RatioIs 2DR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2DR income statement (TTM) | |
|---|---|
| Revenue | US$755.59m |
| Cost of Revenue | US$115.05m |
| Gross Profit | US$640.54m |
| Other Expenses | US$607.49m |
| Earnings | US$33.05m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.10 |
| Gross Margin | 84.77% |
| Net Profit Margin | 4.37% |
| Debt/Equity Ratio | 0% |
How did 2DR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 00:35 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Inspire Medical Systems, Inc. is covered by 24 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| David Rescott | Baird |
| Ravi Misra | Berenberg |